GMED FINANCIAL STATEMENTS

Globus Medical — balance sheet, income statement and cash flow trends

GMEDGlobus Medical

🇺🇸 USA · NYSE · Healthcare · Medical Devices

Value it Duel

Income Statement

Quarterly progression — trailing-twelve-month values

RevenueNet Income

Profit Funnel

Q1 2026 · TTM

Percentages are relative to revenue.

Key Figures

YoY change

Revenue3.1 B $+23.5%

Gross Profit2.1 B $+38.3%

Operating Income546.4 M $+114.3%

EBITDA879.9 M $+59.5%

Net Income586.7 M $+216.2%

Peer Comparison· Medical Devices

Company	Rev. Growth	Gross Margin	EBITDA Margin	Net Margin
GMED	23.5%	67.9%	28.4%	18.9%
COH	2.0%	73.0%	24.0%	14.6%
PHIA	-1.9%	45.2%	15.4%	5.5%
SHL	-0.3%	38.0%	19.1%	9.1%
4DX	-26.0%	-396.6%	-818.8%	-3,684.6%
Industry median	7.4%	58.9%	5.2%	-5.7%

Company	Rev. Growth	Gross Margin	EBITDA Margin	Net Margin
GMED	23.5%	67.9%	28.4%	18.9%
PODD	31.9%	71.0%	19.8%	10.4%
PEN	17.3%	67.4%	15.2%	11.8%
MASI	-14.4%	61.7%	22.1%	4.9%
BRKR	0.4%	45.6%	8.8%	-0.3%
GKOS	36.3%	78.1%	-26.1%	-34.3%
Industry median	7.4%	58.9%	5.2%	-5.7%

Balance Sheet

Quarterly period-end values

Total AssetsTotal LiabilitiesEquity

Capital Structure

Q1 2026

Equity4.7 B $87%
Current Liabilities482.5 M $9%
Long-term Liabilities224.8 M $4%

Key Figures

YoY change

Total Assets5.4 B $+15.5%

Total Liabilities707.2 M $+13.5%

Total Equity4.7 B $+15.8%

Cash & ST Investments629.9 M $+36.5%

Total Debt115.2 M $+24.8%

Net Debt-445.7 M $—

Peer Comparison· Medical Devices

Company	Current Ratio	Debt/Equity	NetDebt/EBITDA	Equity/Assets
GMED	4.56	2.4%	-0.58	87.0%
COH	2.46	22.1%	0.42	69.4%
PHIA	1.32	71.1%	2.03	41.8%
SHL	1.10	84.1%	3.04	40.6%
4DX	6.57	-22.6%	0.71	-20.4%
Industry median	3.28	44.7%	0.82	49.7%

Company	Current Ratio	Debt/Equity	NetDebt/EBITDA	Equity/Assets
GMED	4.56	2.4%	-0.58	87.0%
PODD	2.49	72.8%	0.81	43.6%
PEN	6.02	14.7%	-0.11	77.6%
MASI	2.68	61.6%	1.05	48.0%
BRKR	1.55	68.2%	5.08	39.9%
GKOS	5.43	15.4%	1.21	75.1%
Industry median	3.28	44.7%	0.82	49.7%

Cash Flow Statement

Quarterly progression — trailing-twelve-month values

Operating Cash FlowCapital ExpendituresFree Cash Flow

Cash Flow Bridge

Q1 2026 · TTM

Key Figures

YoY change

Operating Cash Flow778.5 M $+20.6%

Capital Expenditures178.2 M $+39.3%

Free Cash Flow600.3 M $+16.0%

Dividends Paid——

Peer Comparison· Medical Devices

Company	CF Margin	FCF Margin	CapEx Ratio	CF/Net Income
GMED	25.1%	19.4%	5.7%	132.7%
COH	11.2%	8.5%	2.7%	76.6%
PHIA	13.0%	10.8%	2.2%	236.4%
SHL	12.2%	8.7%	3.5%	134.0%
4DX	-761.6%	-530.7%	3.7%	20.7%
Industry median	7.2%	1.5%	4.1%	76.6%

Company	CF Margin	FCF Margin	CapEx Ratio	CF/Net Income
GMED	25.1%	19.4%	5.7%	132.7%
PODD	21.3%	14.2%	7.1%	204.5%
PEN	19.0%	14.6%	4.4%	161.7%
MASI	14.9%	13.4%	1.5%	304.1%
BRKR	4.1%	1.5%	2.6%	-1,209.5%
GKOS	-1.6%	-3.4%	1.8%	4.6%
Industry median	7.2%	1.5%	4.1%	76.6%

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on GMED

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 8, 26. This content is for informational purposes only and is not investment advice.